| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 13 |
| 1 | LEVOTHYROXINE SODIUM | 5 |
| 2 | ETANERCEPT | 4 |
| 3 | METHOTREXATE SODIUM | 4 |
| 4 | ATENOLOL | 3 |
| 5 | CONJUGATED ESTROGENS | 3 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 3 |
| 7 | ESTROGENS, CONJUGATED | 3 |
| 8 | METHOTREXATE | 3 |
| 9 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 1 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 2 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 4 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 5 | TRALOKINUMAB-LDRM | 1 | 0.0001 |
| 6 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 3 | 0.0001 |
| 7 | ALENDRONATE SODIUM | 13 | 0.0001 |
| 8 | PRIMIDONE | 1 | 0.0001 |
| 9 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 1 | Provitamin D2 Compound [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 3 |
| 3 | Estrogen [EPC] | 3 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 5 | Proton Pump Inhibitor [EPC] | 3 |
| 6 | Vitamin B12 [EPC] | 3 |
| 7 | Vitamin D [EPC] | 3 |
| 8 | beta-Adrenergic Blocker [EPC] | 3 |
| 9 | Androgen [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 2 | Androgen [EPC] | 2 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 8 | Estrogen [EPC] | 3 | 0.0000 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 2 | 0.0000 |